Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and LeptinNirav R. Shah(Stanford University), Eric R. Braverman(Rome Foundation)PLoS ONEApril 2, 201210.1371/journal.pone.0033308Cited by 551SaveCiteExport RISWatch citationsRelated Papers<i>In Silico</i> Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder|Current Neuropharmacology|2025|9